Bausch Health Companies (BHC) Gross Margin Growth (3y) (2012 - 2026)
Bausch Health Companies (BHC) Gross Margin Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 631.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 106.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -673.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -675.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -838.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 33.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -344.00 |
| 10 | Bausch Health Companies | 1.66 Bn | 1.33 Bn | 2.52 Bn | 2,942.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,942.00 |
| Dec 31, 2025 | -7,450.00 |
| Sep 30, 2025 | 2,748.00 |
| Jun 30, 2025 | 2,757.00 |
| Mar 31, 2025 | 2,790.00 |
| Dec 31, 2024 | -2,060.00 |
| Sep 30, 2024 | 2,269.00 |
| Jun 30, 2024 | 38.00 |
| Mar 31, 2024 | 49.00 |
| Dec 31, 2023 | -6,735.00 |
| Sep 30, 2023 | -2,678.00 |
| Jun 30, 2023 | -2,875.00 |
| Mar 31, 2023 | -2,873.00 |
| Dec 31, 2022 | 171.00 |
| Sep 30, 2022 | -2,742.00 |
| Jun 30, 2022 | -192.00 |
| Mar 31, 2022 | -2,730.00 |
| Dec 31, 2021 | -5,552.00 |
| Sep 30, 2021 | -2,677.00 |
| Jun 30, 2021 | 9.00 |